Press & news - FluoGuide A/S

1 July, 2026 Update on 2026 Outlook and Company progress News Corporate Action Other mfn-ext-nq mfn-ext-nq-corporate-action English IR

Copenhagen, Denmark, 1 July 2026 – FluoGuide A/S ("FluoGuide" or the "Company"), a clinical-stage biotech...

29 June, 2026 FluoGuide announces positive results from Phase 2 oral head and neck cancer trial News Corporate Information Other Corporate Information mfn-ext-nq mfn-ext-nq-company-announcement English IR

Copenhagen, Denmark, 29 June 2026 – FluoGuide A/S (“FluoGuide” or the “Company”), a biotech company maximizing...

27 May, 2026 FluoGuide A/S publishes interim report for Q1 2026 News English Regulatory Listing Regulation Report Interim Q1 IR

Copenhagen, Denmark, 27 May 2026 – Fluoguide A/S (“FluoGuide” or the “Company”) today releases its results...

13 May, 2026 Invitation to brain surgery simulation News Corporate Information Other Corporate Information mfn-ext-nq mfn-ext-nq-company-announcement English IR

Copenhagen, Denmark, 13 May 2026 – FluoGuide A/S ("FluoGuide" or the "Company") is inviting investors to...

13 May, 2026 Invitation to FluoGuide A/S live webcast on 27 May 2026 News Corporate Information Other Corporate Information mfn-ext-nq mfn-ext-nq-company-announcement English IR

FluoGuide A/S will publish its interim report for Q1 2026 on Wednesday, 27 May 2026. Later that day, CEO Morten Albrechtsen and CFO...

10 April, 2026 Positive interim results from an investigator-initiated study of FG001 in meningioma and low-grade glioma surgery, re-presented at SNOG News Corporate Information Other Corporate Information mfn-ext-nq mfn-ext-nq-company-announcement English IR

Copenhagen, Denmark, 10 April 2026 – FluoGuide A/S ("FluoGuide" or the "Company"), a clinical-stage biotech...

25 March, 2026 Minutes from Annual General Meeting in FluoGuide A/S News Corporate Information General meeting Report of the AGM English Regulatory Listing Regulation IR

Copenhagen, Denmark, 25 March 2026 – FluoGuide A/S (“FluoGuide” or the “Company”) held its annual general...

18 March, 2026 FluoGuide receives FDA Fast Track Designation for FG001 in high-grade glioma News Corporate Information Other Corporate Information mfn-ext-nq mfn-ext-nq-company-announcement English Regulatory MAR IR

Copenhagen, Denmark, 18 March 2026 – FluoGuide A/S (“FluoGuide” or the “Company”), a biotech company...

10 March, 2026 Notice of Annual General Meeting in FluoGuide A/S News Corporate Information General meeting Notice English Regulatory Listing Regulation IR

The board of directors hereby convenes the Annual General Meeting of FluoGuide A/S, company registration (CVR) no. 39 29 64 38 (the...

2026

FluoGuideCalendar & events